| Date | Time | Source | Headline | Symbol | Company |
| 04/30/2024 | 12:53PM | iHub Newswire | FeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia | | |
| 01/21/2020 | 5:16PM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/17/2020 | 4:10PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/17/2020 | 4:06PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/16/2020 | 8:01AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/15/2020 | 6:04AM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/13/2020 | 6:56PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/13/2020 | 6:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/13/2020 | 6:48PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/10/2020 | 5:26PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 01/09/2020 | 1:43PM | GlobeNewswire Inc. | ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/31/2019 | 4:06PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/31/2019 | 4:05PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/23/2019 | 5:00PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/20/2019 | 4:06PM | Edgar (US Regulatory) | Withdrawal of Registration Statement (rw) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/20/2019 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/19/2019 | 4:26PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/18/2019 | 5:46PM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/17/2019 | 6:03AM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/05/2019 | 6:04AM | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 12/03/2019 | 5:45PM | PR Newswire (US) | Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina T... | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/22/2019 | 10:37AM | PR Newswire (US) | Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), an... | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/21/2019 | 5:33PM | PR Newswire (US) | SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc. | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/21/2019 | 5:02PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/21/2019 | 5:00PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/14/2019 | 4:22PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/14/2019 | 4:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/14/2019 | 4:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/14/2019 | 6:04AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
| 11/12/2019 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PRTO | Proteon Therapeutics Inc |